Brief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
17/10/2024 20:10
Oct 17 (Reuters) - Replicel Life Sciences Inc RP.V :
* REPLICEL LIFE SCIENCES - ANNOUNCES REINSTATEMENT OF TRADING & CONDITIONAL ACCEPTANCE FOR
PROPOSED TRANSACTION
* REPLICEL LIFE SCIENCES - INTENDS TO MANAGE ITS WORKING CAPITAL CONCERNS THROUGH ITS
SECURED LOAN
WITH ANDREW SCHUTTE
* REPLICEL LIFE SCIENCES - RECEIVED CONDITIONAL ACCEPTANCE FROM EXCHANGE FOR PROPOSED
DISPOSITION
OF ASSETS TO 1456390 B.C. LTD
Further company coverage: RP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector